Buy Zanaflex
Zanaflex

0.79
Zanaflex (tizanidine) is a muscle relaxant used to treat spasms and muscle tightness. It works by temporarily slowing down the action of the nervous system, allowing muscles to relax and easing the discomfort associated with various physical conditions.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Active Ingredient(s)
Tizanidine
Reference Brand
Zanaflex
Product Form
Tablet, Capsule
Regulatory Classification
Rx
Primary Category
Muscle Relaxant
Product Category
Muscle relaxants, Centrally acting agents
Pharmacological Class
Alpha-2 Adrenergic Agonists
Manufacturer Description
A short-acting muscle relaxant used to manage spasms and increased muscle tone caused by neurological conditions.
Mechanism of Action
Tizanidine works by blocking nerve impulses (pain sensations) that are sent to the brain. It is a short-acting drug that increases presynaptic inhibition of motor neurons by acting on alpha-2 adrenergic receptors, thereby reducing muscle tone and spasms.
Route of Administration
Oral
Onset Time
1-2 hours
Duration
3-6 hours
Contraindications
Severe liver impairment, Concomitant use with ciprofloxacin, Concomitant use with fluvoxamine
Severe Adverse Events
Hepatotoxicity, Severe hypotension, Hallucinations, Fainting
Common Side Effects
Drowsiness, Dizziness, Dry mouth
Uncommon Side Effects
Fatigue, Weakness, Low blood pressure, Bradycardia
Drug Interactions
Ciprofloxacin, Fluvoxamine, Oral contraceptives, Alcohol
Pregnancy Safety Warnings
Use only if benefit outweighs risk. Consult a doctor.
Age Restrictions
Safety not established in children
Storage Guidelines
Store at room temperature away from moisture.
Related Products
Baclofen, Diazepam, Dantrolene

Zanaflex FAQ

Can Zanaflex be taken on an empty stomach?

Zanaflex may be taken with or without food. A high-fat meal can slightly delay its absorption, but this does not usually affect overall effectiveness. If gastrointestinal upset occurs, taking the tablet with a small amount of food may help.

What should I do if I feel unusually dizzy after a dose?

Dizziness is a common side effect, especially when standing quickly. Sit or lie down until it passes, avoid driving or operating machinery, and inform your prescriber if the symptom persists or worsens.

Is Zanaflex safe for people with mild kidney disease?

Mild to moderate renal impairment does not typically require dose adjustment because tizanidine is cleared mainly by the liver. Nevertheless, a healthcare professional should review kidney function before initiating therapy.

How does Zanaflex differ from baclofen for muscle spasticity?

Both are muscle-relaxants, but tizanidine (Zanaflex) works via α₂-adrenergic agonism, whereas baclofen acts on GABA-B receptors. Their side-effect profiles, dosing schedules, and drug-interaction potentials differ, making the choice dependent on individual patient factors.

Can I travel internationally with Zanaflex tablets?

Yes, provided you carry the original prescription label and a copy of the prescription. Some countries may require additional documentation; check the destination’s medication import regulations before travel.

Will Zanaflex show up on a drug test for employment or sport?

Tizanidine is not typically included in standard workplace or anti-doping screening panels. However, specialized tests can detect it if specifically requested, so disclose its use if required.

Are there any over-the-counter supplements that interact with Zanaflex?

Herbal products that inhibit CYP1A2-such as cocoa or certain St. John’s wort preparations-may increase tizanidine levels. Always discuss supplement use with your pharmacist or prescriber.

What inactive ingredients are in Zanaflex tablets?

Common excipients include lactose monohydrate, microcrystalline cellulose, and magnesium stearate. Patients with severe lactose intolerance should consult their prescriber for alternative formulations.

Why does Zanaflex sometimes cause dry mouth, and how can I manage it?

Dry mouth results from reduced salivary secretion due to central nervous system effects. Sip water frequently, chew sugar-free gum, or use saliva substitutes to alleviate discomfort.

Is it possible to become dependent on Zanaflex?

Physical dependence is uncommon, but abrupt discontinuation after long-term use can lead to rebound hypertension and increased spasticity. Tapering the dose under medical supervision minimizes these risks.

What is Zanaflex?

Zanaflex is a prescription-only (POM) medication marketed in the United Kingdom under the brand name Zanaflex. Its active ingredient is tizanidine, a centrally acting muscle-relaxant that belongs to the broader class of pain-relief agents used to treat muscle spasticity. Zanaflex is supplied as a pill in two strengths: 2 mg and 4 mg tablets. The Medicines and Healthcare products Regulatory Agency (MHRA) authorises its use for adults who require relief from abnormal muscle tone associated with certain neurological conditions.

How Zanaflex Works in the Body

Tizanidine exerts its therapeutic effect primarily by stimulating α₂-adrenergic receptors in the central nervous system. Activation of these receptors reduces the release of excitatory neurotransmitters such as glutamate and substance P, which in turn diminishes the firing of motor neurons that cause involuntary muscle contraction. The result is a decrease in muscle tone, leading to reduced spasticity and associated pain.

Key pharmacologic points:

  • Onset of action: Typically within 30-60 minutes after oral ingestion.
  • Peak effect: Reached about 1-2 hours post-dose.
  • Duration: Effects generally last 4-6 hours, guiding the usual dosing frequency.
  • Metabolism: Predominantly hepatic via the CYP1A2 enzyme; renal excretion is minimal.

Conditions Treated by Zanaflex

Zanaflex is approved by the MHRA for the treatment of spasticity that arises from:

  • Multiple sclerosis (MS)
  • Spinal cord injury (SCI)
  • Other neurological disorders causing muscle hypertonicity

The medication is intended for adults who experience muscle stiffness, pain, and impaired mobility due to these conditions. It is not indicated for general pain relief unrelated to spasticity.

Patient Suitability and Contraindications

Absolute Contraindications

  • Known hypersensitivity to tizanidine or any tablet excipients.
  • Severe hepatic impairment (Child-Pugh class C).
  • Concomitant use with ciprofloxacin (potentiates tizanidine’s effects and can cause profound hypotension).

Relative Contraindications

  • Moderate hepatic dysfunction (Child-Pugh class A or B).
  • Uncontrolled low blood pressure or a history of syncope.
  • Pregnancy (use only if the potential benefit justifies the potential risk to the fetus).
  • Breast-feeding (tizanidine is excreted in breast milk; caution advised).

Special Populations

  • Elderly: May be more sensitive to sedative effects; start at the lowest dose and titrate slowly.
  • Renal impairment: No dose adjustment is required for mild to moderate renal dysfunction, but severe impairment should be managed under specialist supervision.

If any of the above conditions apply, a healthcare professional should evaluate the risks before prescribing Zanaflex.

Safety Profile

Common Side Effects

  • Dry mouth
  • Drowsiness or fatigue
  • Weakness (muscle weakness)
  • Dizziness, especially when standing quickly (orthostatic hypotension)

These effects are generally mild and often improve as the body adjusts to the medication.

Serious Adverse Events

  • Severe hypotension or syncope
  • Hepatotoxicity (elevated liver enzymes, jaundice) - rare but requires prompt medical review
  • Bradycardia (slow heart rate)
  • Allergic reactions such as rash, itching, or swelling

If any of these serious symptoms appear, seek urgent medical attention.

Drug Interactions

  • Major: Ciprofloxacin - can increase tizanidine plasma concentrations up to tenfold; co-administration is contraindicated.
  • Moderate: Fluvoxamine, cimetidine, and macrolide antibiotics (e.g., erythromycin) - may raise tizanidine levels, requiring dose reduction and close monitoring.
  • CYP1A2 inhibitors (e.g., oral contraceptives, certain antipsychotics) - can modestly increase exposure; clinicians often start at a lower dose.

Patients should disclose all prescription medicines, over-the-counter products, herbal supplements, and vitamins before initiating Zanaflex.

Food and Lifestyle Interactions

  • Alcohol: May amplify sedative and hypotensive effects; limit intake.
  • Food: Zanaflex can be taken with or without food, but a high-fat meal may slightly delay absorption.
  • Driving: Because of possible dizziness or drowsiness, avoid operating heavy machinery until the individual’s response to the drug is known.

How to Take Zanaflex

  • Standard dosing: Begin with one 2 mg tablet taken at bedtime. If tolerated, the dose may be increased by 2 mg increments every 3-4 days. The usual maintenance range is 2-8 mg per day, divided into two or three doses. Tablets are available in 2 mg and 4 mg strengths, allowing flexible titration.
  • Maximum dose: Do not exceed 24 mg per day (i.e., six 4 mg tablets) unless specifically directed by a prescriber.
  • Administration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised.
  • Missed dose: If a dose is missed and it is less than 6 hours until the next scheduled dose, skip the missed tablet and resume the regular schedule. Do not double-dose.
  • Overdose: Symptoms may include severe drowsiness, hypotension, and respiratory depression. Seek emergency medical care immediately; treatment is primarily supportive.
  • Discontinuation: Tizanidine should be tapered gradually rather than stopped abruptly, especially after prolonged use, to minimise withdrawal symptoms such as rebound hypertension or increased spasticity.

Monitoring and Follow-Up

  • Liver function tests (LFTs): Baseline testing before starting therapy and periodic monitoring (e.g., every 3-6 months) for patients at risk of hepatic dysfunction.
  • Blood pressure: Check regularly, especially after dose adjustments, because of the risk of hypotension.
  • Clinical assessment: Evaluate spasticity scores and functional improvement at each follow-up visit. Adjust dosing based on therapeutic response and tolerability.

Storage and Handling

  • Store Zanaflex tablets at room temperature (≤ 25 °C), protected from light and moisture.
  • Keep the container tightly closed and out of reach of children.
  • Do not use tablets after the expiry date printed on the packaging.
  • For safe disposal, return unused medication to a pharmacy’s take-back scheme or follow local NHS guidelines for household waste.

Medication-Specific Glossary

α₂-Adrenergic Agonist
A drug that activates α₂-adrenergic receptors, leading to reduced sympathetic outflow and decreased muscle tone.
Spasticity
A condition characterized by involuntary muscle stiffness and exaggerated reflexes, commonly seen in neurological disorders such as multiple sclerosis.
Hepatic Metabolism (CYP1A2)
The process by which the liver enzyme CYP1A2 breaks down tizanidine; substances that inhibit this enzyme can raise tizanidine levels.
Rebound Hypertension
An increase in blood pressure that can occur when a centrally acting agent like tizanidine is stopped suddenly after long-term use.

Medical Disclaimer

This article provides educational information about Zanaflex and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Information for Zanaflex is sourced from established medical standards and updated frequently. It is provided for general guidance and should be confirmed with a healthcare professional before use.
Categories